Capital Group Core Equity ETF (CGUS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
45.21 - Open
45.24 - Bid 45.17 x 290000
- Ask 45.22 x 720000
- Day's Range
45.09 - 45.32 - 52 Week Range
37.19 - 46.80 - Volume
1,166,637 - Avg. Volume
1,129,709 - Net Assets 11.81B
- NAV 44.88
- PE Ratio (TTM) 27.12
- Yield 0.82%
- YTD Daily Total Return 12.10%
- Beta (5Y Monthly) 0.94
- Expense Ratio (net) 0.33%
Performance Overview
View MoreTrailing returns as of 9/2/2026. Category is Large Blend.
Holdings
View MoreTop 10 Holdings (42.23% of Total Assets)
Sector Weightings
Related ETF News
View MoreResearch Reports
View More-
Daily – Vickers Top Insider Picks for 09/03/2026
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
-
Boston Scientific Earnings: Competitive Pressure Closing in on Key Growth Areas
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
RatingPrice Target -
Raising target price and EPS estimates on outlook
Johnson & Johnson is a diversified global healthcare company that develops, manufactures, and markets products in two business segments: Innovative Medicine (formerly Pharmaceuticals) and MedTech.
RatingPrice Target -
Johnson & Johnson Earnings: Steady Growth and Good Near-Term Visibility; Maintaining Our FVE
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of the total revenue is generated in the United States.
RatingPrice Target



